STATE STREET CORP - DURATA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$2,275,000
-24.9%
179,411
+0.9%
0.00%
Q2 2014$3,031,000
+27.6%
177,894
+0.7%
0.00%
Q1 2014$2,376,000
-5.5%
176,572
-15.3%
0.00%
Q4 2013$2,514,000
+95.3%
208,377
+46.6%
0.00%
Q3 2013$1,287,000
+32.5%
142,133
+5.3%
0.00%
Q2 2013$971,000135,0270.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders